Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Bank of Hawaii (BOH) trades at roughly $75.81 with a market cap near $3.0B, a P/E around 14x and a P/B near 1.6x. Rising interest rates and prior bond markdowns pressured capital and share price, but those same forces are now a multi-year tailwind as asset repricing lifts net interest margins and frees capital. This trade recommends a long entry wi…
Powell Industries just delivered record quarterly orders and a $2.4B backlog. The thesis: the market has already priced much of the growth, but a disciplined long positioned around operational execution and order conversion can capture upside as revenue turns into higher EPS and free cash flow. Entry: $182.39. Target: $260.00. Stop: $150.00. Time h…
Axe Compute Inc. announced a non-qualified stock option grant of 60,000 shares at $10.67 per share to a new non-executive employee under Nasdaq Listing Rule 5635(c)(4). The option, granted outside the company's equity incentive plan, vests over three years and has a 10-year term. Axe Compute is a neocloud AI infrastructure provider based in Pittsbu…
Booking Holdings offers a more defensible, cash-generative exposure to travel than Expedia right now. At $174, Booking trades at reasonable multiples versus its cash flow and carries a steady dividend, improving the risk-reward for a mid-term long trade. Execution risks and macro sensitivity remain; set a clear stop and watch catalysts closely.
Applied Materials (AMAT) stands to be a direct beneficiary of another cycle of semiconductor capital spending driven by AI and advanced packaging. With $5.6B in free cash flow, strong profitability (ROE ~36%), and a conservative balance sheet (debt/equity ~0.26), we move to Accumulate. This is a measured trade: enter near $455, stop at $420, and ta…
Cipher Digital (CIFR) is executing a pivot from crypto mining to hyperscale AI data centers. Recent lease wins and financing milestones have re-anchored the story, yet Q2 misses, negative cash flow and a high EV/sales multiple keep the stock volatile. We lay out a mid-term swing long with a clear entry, stop and target and explain the catalysts and…
EverCommerce Inc. announced that its Board of Directors has approved a $25 million increase to its existing $300 million share repurchase program, raising the total authorization to $325 million, extending the buyback program through December 31, 2027. The company plans to fund repurchases with cash on hand and may repurchase shares through open ma…
Grupo Aeroportuario del Pacífico (PAC) announced the execution of credit facilities amounting to Ps. 8,000 million with major banks including Santander, BBVA, HSBC, J.P. Morgan, and Scotiabank. The funds will be used primarily to repay maturing long-term debt certificates in September and October 2026, and to finance capital expenditures as part of…
Expro (XPRO) is a niche oilfield-services play benefiting from rising well complexity and a $2.3B contract backlog. With recent beat in Q2 2025 revenue ($422.7M) and a market cap near $1.97B, the risk/reward favors a tactical long over the next 45 trading days as contracts roll into revenue and margin mix improves. Entry at $17.58, target $20.00, s…
Eastern International Ltd. (NASDAQ: ELOG) announced it received a Nasdaq notification for failing to meet the minimum bid price requirement of $1.00 per share for 30 consecutive trading days. The company now has 180 calendar days to regain compliance with this requirement or risk eventual delisting. Management will monitor the stock price and consi…
ArrowMark Financial Corp., a Nasdaq-listed closed-end management investment company, announced a special cash distribution of $0.10 per share along with the regular monthly cash distribution of $0.15 per share for September 2026. The distributions underscore the company's ability to consistently exceed its declared quarterly distribution rate, emph…
Rainier Acquisition Corporation announced that starting September 14, 2026, holders of its units can elect to separately trade Class A ordinary shares and warrants on Nasdaq. The units include one Class A share and one-quarter of a redeemable warrant. Separate trading for Class A shares and warrants will begin on September 15, 2026, under ticker sy…
Arteris, Inc. announced inducement equity awards granted to its new CFO, Saurabh Sinha. The awards include restricted stock units valued at $3.7 million and performance stock units valued at $1 million, with vesting linked to continued employment and specific revenue and share price targets. The grants aim to incentivize senior management alignment…
Standard Lithium Ltd. announced the resignation of board member Karen Narwold due to new executive commitments. The company is searching for a new independent director to complement its existing board and support its growth and strategic goals. Standard Lithium is focused on developing high-grade lithium-brine projects in the U.S., including partne…
AMREP Corporation reported a sharp decline in net income and revenues for the first quarter of fiscal 2027 compared to the same period in the prior year. Net income fell to $276,000 ($0.05 per diluted share) from $4.69 million ($0.87 per diluted share), while revenues dropped from $17.85 million to $6.05 million. The company noted that results can …
Cellectis, a clinical-stage biotech company specializing in gene-editing CAR T immunotherapies, will hold a conference call and webcast on September 14, 2026, to provide a business update. The event will cover progress in its oncology and gene therapy programs using off-the-shelf allogeneic CAR T-cells.
Biodexa Pharmaceuticals PLC announced its unaudited interim results for the six months ended June 30, 2026. Key developments include the in-license of MTX240 from Otsuka, expansion of its Phase 3 trial for eRapa in Familial Adenomatous Polyposis (FAP), Health Canada approval for trial expansion, and a post-period $3.5 million fundraise. R&D costs i…
Star Bulk Carriers Corp. completed a public offering of 4,400,000 new common shares priced at €24.50 (US$28.40) each, leading to a total demand over six times the shares issued, signaling strong investor interest. The shares will be listed on the Euronext Athens market alongside existing listings, with the offering restricted to non-U.S. persons un…
CEA Industries Inc. reported a net loss of $11.4 million for Q1 fiscal 2027, driven by $15.3 million unrealized loss on digital assets primarily BNB tokens. The company holds over 515,000 BNB tokens valued at approximately $302 million, representing the largest corporate BNB treasury. Operational revenue declined slightly due to product discontinua…
Kite Realty Group, a publicly traded real estate investment trust focused on open-air shopping centers and mixed-use destinations primarily in the Sun Belt and gateway markets, announced it will present at the upcoming BofA Securities 2026 Global Real Estate Conference. The presentation will provide updates on the company's business and investment …
Impact BioMedical Inc. declared a 1-for-12.62 reverse stock split effective September 23, 2026, aimed at supporting its proposed merger with pharmaceutical company Zoar Ltd and maintaining NYSE American listing standards. The merger will create a combined company with expertise in manufacturing and clinical development of active pharmaceutical ingr…
Agomab Therapeutics NV announced that shareholders approved key resolutions including the appointment of Marino Garcia and Dr. Naimish Patel as non-executive board members. These appointments are expected to enhance the Company's strategic direction and oversight as it advances its clinical-stage pipeline targeting fibro-inflammatory diseases. Addi…
Corbus Pharmaceuticals Holdings, a clinical-stage biotech company focusing on oncology and obesity treatments, announced a conference call scheduled for September 14, 2026, to discuss topline data from its CANYON-1 Phase 1b trial evaluating CRB-913, an oral CB1 inverse agonist aimed at treating obesity. The trial involved 240 obese, non-diabetic ad…
The Bancorp (TBBK) is trading near its 52-week low despite improving fintech fee growth, expanding deposits, and healthy profitability metrics. With a trailing P/E near 9x, a $2.06B market cap, and clear cost-containment efforts, the risk-reward favors a tactical long over the next 45 trading days if management continues execution. This trade idea …
Chevron is trading near multi-month highs with a 3.3%+ yield, robust free cash flow, low net leverage and material upside if $100 oil persists. I lay out a concrete long trade: entry $214.04, stop $197.00, target $255.00 (180 trading days) plus shorter horizon guidance. The set-up balances cyclical oil exposure with solid downstream cash generation…
